Carregando...
Blocking extracellular Galectin-3 in patients with osteoarthritis
OBJECTIVE: This pilot clinical trial examined the efficacy of blocking extracellular Galectin-3 (Gal-3) with modified citrus pectin (MCP), in patients suffering from knee osteoarthritis (OA). METHODS: 50 patients were randomized in a 1:1 ratio to receive MCP or placebo at a dose of 4 g (5 capsules)...
Na minha lista:
| Publicado no: | Contemp Clin Trials Commun |
|---|---|
| Principais autores: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6909224/ https://ncbi.nlm.nih.gov/pubmed/31872160 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.conctc.2019.100500 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|